DECAF Score Calculator – COPD Exacerbation Mortality Risk

Clinical calculation support · Verify results before clinical use

DECAF Score Assessment

Assess admission variables in adults hospitalized with an acute exacerbation of COPD.

—Score / 6
D

Dyspnoea – Extended MRC (eMRCD)

Assess usual breathlessness on a good day during the 3 months before this exacerbation, not current breathlessness.

0–2 points
E

Eosinopenia

Admission blood eosinophil count. Enter the absolute count in the specified unit.

+1 point
× 10⁹/L

Eosinopenia is defined as <0.05 × 10⁹/L. A value exactly equal to 0.05 does not score.

C

Consolidation on chest radiograph

Radiographic consolidation on the admission chest X-ray.

+1 point
A

Acidaemia

Admission arterial blood gas (ABG): pH <7.30.

+1 point
F

Atrial fibrillation

Atrial fibrillation on admission ECG or a known history of paroxysmal atrial fibrillation.

+1 point
—DECAF
In-hospital mortality risk category
Complete required inputs
Select or enter all admission variables to calculate the score.
Clinical interpretationThe DECAF score is a prognostic aid for patients hospitalized with an acute exacerbation of COPD. It does not determine treatment or place of care on its own.

Risk groups: 0–1 = low, 2 = intermediate, and 3–6 = high in-hospital mortality risk. These are risk strata, not an individualized mortality percentage.

About the DECAF Score

The DECAF (Dyspnoea, Eosinopenia, Consolidation, Acidaemia and atrial Fibrillation) score was developed to predict in-hospital mortality among adults admitted to hospital with an acute exacerbation of COPD.

The score ranges from 0 to 6. The extended MRC dyspnoea component contributes 0, 1 or 2 points; each of the remaining four components contributes 0 or 1 point.

Scoring criteria

VariableCriterionPoints
DyspnoeaeMRCD 1–4 / 5a / 5b0 / 1 / 2
EosinopeniaAbsolute eosinophils <0.05 × 10⁹/L+1
ConsolidationConsolidation on admission chest X-ray+1
AcidaemiaAdmission arterial pH <7.30+1
Atrial fibrillationOn ECG or known paroxysmal AF+1

Risk interpretation

DECAF scoreRisk categoryOutcome predicted
0–1LowLow in-hospital mortality risk
2IntermediateIntermediate in-hospital mortality risk
3–6HighHigh in-hospital mortality risk

Important scoring notes

  • Assess eMRCD from the patient's usual state on a good day in the 3 months before the current exacerbation.
  • eMRCD 5a means too breathless to leave home unaided but independent in washing and/or dressing. eMRCD 5b means housebound and dependent for washing and dressing.
  • Eosinophil count is an absolute count, not a percentage.
  • If ABG is not obtained, the validation study supports assigning 0 for acidaemia only when SpO₂ is >92% while breathing room air. Otherwise the pH component is unresolved.

References

Steer J, Gibson J, Bourke SC.The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67(11):970–976. DOI: 10.1136/thoraxjnl-2012-202103.
Echevarria C, Steer J, Heslop-Marshall K, et al.Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD. Thorax. 2016;71(2):133–140. DOI: 10.1136/thoraxjnl-2015-207775.
Shen Y, et al.DECAF score as a mortality predictor for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMJ Open. 2020. DOI: 10.1136/bmjopen-2020-037923.
Global Initiative for Chronic Obstructive Lung Disease (GOLD).Global Strategy for the Diagnosis, Management, and Prevention of COPD: 2026 Report. GOLD notes that available prognostic scores have limitations and does not recommend their routine use. Official GOLD report.
Clinical disclaimer: The DECAF score is a prognostic tool, not a diagnostic test or a stand-alone treatment/disposition rule. It was developed for adults hospitalized with an acute COPD exacerbation. Interpret results alongside the full clinical assessment, comorbidities, physiological status, investigations, patient preferences, and local pathways. Do not use this score to delay escalation of care in a deteriorating patient. GOLD 2026 does not recommend routine use of prognostic scores because of their limitations.